Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia

被引：0
|
作者：
Fraietta, Joseph A.
Lacey, Simon F.
Orlando, Elena
Pruteanu, Julian
Gohil, Mercy
Wang, Yan
Boesteanu, Alina
OConnor, Roddy
Ambrose, David E.
Hwang, Wei-Ting
Wilcox, Nicholas
Bedoya, Felipe
Dorfmeier, Corin
Chen, Fang
Parakandi, Harit
Gupta, Minnal
Pequignot, Edward
Johnson, F. Brad
Kulikovskaya, Irina
Liu, Li
Lundh, Stefan M.
Xu, Jun
Davis, Megan M.
Young, Regina M.
Levine, Bruce L.
Siegel, Don L.
Huang, Alexander
Wherry, E. John
Zhou, Jing
Paczkowski, Patrick
Mackay, Sean
Brogdon, Jennifer
Bitter, Hans
Porter, David L.
June, Carl H.
Melenhorst, J. Joseph
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3181
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
    Fraietta, Joseph A.
    Lacey, Simon F.
    Orlando, Elena J.
    Pruteanu-Malinici, Iulian
    Gohil, Mercy
    Lundh, Stefan
    Boesteanu, Alina C.
    Wang, Yan
    O'Connor, Roddy S.
    Hwang, Wei-Ting
    Pequignot, Edward
    Ambrose, David E.
    Zhang, Changfeng
    Wilcox, Nicholas
    Bedoya, Felipe
    Dorfmeier, Corin
    Chen, Fang
    Tian, Lifeng
    Parakandi, Harit
    Gupta, Minnal
    Young, Regina M.
    Johnson, F. Brad
    Kulikovskaya, Irina
    Liu, Li
    Xu, Jun
    Kassim, Sadik H.
    Davis, Megan M.
    Levine, Bruce L.
    Frey, Noelle V.
    Siegel, Donald L.
    Huang, Alexander C.
    Wherry, E. John
    Bitter, Hans
    Brogdon, Jennifer L.
    Porter, David L.
    June, Carl H.
    Melenhorst, J. Joseph
    NATURE MEDICINE, 2018, 24 (05) : 563 - +
  • [2] Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
    Joseph A. Fraietta
    Simon F. Lacey
    Elena J. Orlando
    Iulian Pruteanu-Malinici
    Mercy Gohil
    Stefan Lundh
    Alina C. Boesteanu
    Yan Wang
    Roddy S. O’Connor
    Wei-Ting Hwang
    Edward Pequignot
    David E. Ambrose
    Changfeng Zhang
    Nicholas Wilcox
    Felipe Bedoya
    Corin Dorfmeier
    Fang Chen
    Lifeng Tian
    Harit Parakandi
    Minnal Gupta
    Regina M. Young
    F. Brad Johnson
    Irina Kulikovskaya
    Li Liu
    Jun Xu
    Sadik H. Kassim
    Megan M. Davis
    Bruce L. Levine
    Noelle V. Frey
    Donald L. Siegel
    Alexander C. Huang
    E. John Wherry
    Hans Bitter
    Jennifer L. Brogdon
    David L. Porter
    Carl H. June
    J. Joseph Melenhorst
    Nature Medicine, 2018, 24 : 563 - 571
  • [3] Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
    Joseph A. Fraietta
    Simon F. Lacey
    Elena J. Orlando
    Iulian Pruteanu-Malinici
    Mercy Gohil
    Stefan Lundh
    Alina C. Boesteanu
    Yan Wang
    Roddy S. O’Connor
    Wei-Ting Hwang
    Edward Pequignot
    David E. Ambrose
    Changfeng Zhang
    Nicholas Wilcox
    Felipe Bedoya
    Corin Dorfmeier
    Fang Chen
    Lifeng Tian
    Harit Parakandi
    Minnal Gupta
    Regina M. Young
    F. Brad Johnson
    Irina Kulikovskaya
    Li Liu
    Jun Xu
    Sadik H. Kassim
    Megan M. Davis
    Bruce L. Levine
    Noelle V. Frey
    Donald L. Siegel
    Alexander C. Huang
    E. John Wherry
    Hans Bitter
    Jennifer L. Brogdon
    David L. Porter
    Carl H. June
    J. Joseph Melenhorst
    Nature Medicine, 2021, 27 : 561 - 561
  • [4] Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia (vol 24, pg 563, 2018)
    Fraietta, Joseph A.
    Lacey, Simon F.
    Orlando, Elena J.
    Pruteanu-Malinici, Iulian
    Gohil, Mercy
    Lundh, Stefan
    Boesteanu, Alina C.
    Wang, Yan
    O'Connor, Roddy S.
    Hwang, Wei-Ting
    Pequignot, Edward
    Ambrose, David E.
    Zhang, Changfeng
    Wilcox, Nicholas
    Bedoya, Felipe
    Dorfmeier, Corin
    Chen, Fang
    Tian, Lifeng
    Parakandi, Harit
    Gupta, Minnal
    Young, Regina M.
    Johnson, F. Brad
    Kulikovskaya, Irina
    Liu, Li
    Xu, Jun
    Kassim, Sadik H.
    Davis, Megan M.
    Levine, Bruce L.
    Frey, Noelle V.
    Siegel, Donald L.
    Huang, Alexander C.
    Wherry, E. John
    Bitter, Hans
    Brogdon, Jennifer L.
    Porter, David L.
    June, Carl H.
    Melenhorst, J. Joseph
    NATURE MEDICINE, 2021, 27 (03) : 561 - 561
  • [5] Biomarkers of Response to Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Chronic Lymphocytic Leukemia
    Fraietta, Joseph A.
    Lacey, Simon F.
    Wilcox, Nicholas S.
    Bedoya, Felipe
    Chen, Fang
    Orlando, Elena
    Brogdon, Jennifer L.
    Hwang, Wei-Ting
    Frey, Noelle
    Young, Regina M.
    Pequignot, Edward
    Ambrose, David E.
    Levine, Bruce L.
    Bitter, Hans
    Porter, David L.
    Xu, Jun
    June, Carl H.
    Melenhorst, Jan Joseph
    BLOOD, 2016, 128 (22)
  • [6] CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Systemic Autoimmune Diseases
    Cingireddy, Ananya Reddy
    Flores, Brianna
    Wuthrich, John
    Cingireddy, Anirudh Reddy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [7] Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia
    Bair, Steven M.
    Porter, David L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S10 - S17
  • [8] Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
    Delgado, Julio
    Caballero-Banos, Miguel
    Ortiz-Maldonado, Valentin
    Castella, Maria
    Magnano, Laura
    Juan, Manel
    Urbano-Ispizua, Alvaro
    HEMASPHERE, 2019, 3 (02):
  • [9] Transfusion Support for CD19 Chimeric Antigen Receptor T-Cell Therapy
    Saifee, Nabiha H.
    Cottrell, Ryan
    Kuciel, Ariel
    Gardner, Rebecca A.
    Delaney, Meghan
    TRANSFUSION, 2019, 59 : 194A - 195A
  • [10] A New Frontier: CD19 Chimeric Antigen Receptor T-Cell Therapy
    Alkureishi, Lolita Alcocer
    Hageman, Joseph R.
    PEDIATRIC ANNALS, 2024, 53 (05): : e157 - e158
12345